Sodium valproate pregnancy prevention — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Do not simply continue supply; urgently refer for specialist review and Pregnancy Prevention Programme checks
Valproate is highly teratogenic and is subject to strict risk minimisation measures. A patient planning pregnancy requires urgent specialist review rather than routine continuation or abrupt stopping without medical advice. The pharmacist should ensure the patient understands the risks and is supported to access specialist care.
Reference: MHRA; BNF